Category: Pricing

Pricing, Regulations

Drug rebates were associated with higher out-of-pocket costs for patients

June 16, 2021

Via: Medical News

Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for patients. To investigate whether patients […]

FDA, Industry, News, Pricing, Regulations, Vaccines

US backs proposal to waive IP protection for COVID-19 vaccines

May 7, 2021


The Biden-Harris Administration is backing a proposal from the World Trade Organization (WTO), supported by South Africa and India, that would temporarily remove IP protections on COVID-19 vaccines. The move itself is surprising, given that historically the US has been […]

News, Pricing, Regulations

Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering – Mar 12, 2021

March 12, 2021

Via: BioSpace

Prometheus Biosciences, Inc. (Nasdaq: RXDX), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the pricing of its […]

News, Pricing, Regulations

Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering

February 25, 2021

Via: BioSpace

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock […]

Pricing, Regulations

Decibel Therapeutics Announces Pricing of Initial Public Offering

February 12, 2021

Via: BioSpace

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the pricing of its initial public offering of 7,062,000 shares of its common stock at a […]

FDA, News, Pricing, Regulations

Democratic senators grill U.S. health officials on Trump interference in coronavirus vaccine process

September 9, 2020


Democratic senators on Wednesday grilled U.S. health officials about whether President Donald Trump is interfering in the development of potential coronavirus vaccines. National Institutes of Health Director Dr. Francis Collins and U.S. Surgeon General Dr. Jerome Adams testified before the […]

Pricing, Regulations

Trump invites high-stakes showdown with big pharma as election looms

July 28, 2020

Via: Biopharma Dive

With just over three months before the U.S. elections in November, President Donald Trump is making a last-ditch effort to stamp his name on a drug pricing deal that has eluded him over his first three years in office. A […]

Pricing, Regulations

Drug Pricing Back in the Spotlight

July 21, 2020

Via: PharmTech

As the world waits anxiously for more effective COVID-19 treatments and for a vaccine to halt the pandemic, analysts on all sides are examining appropriate pricing models for these critical products. Gilead’s $3000 price tag on remdesivir ($2300 for US […]

Biotech, Industry, Pricing, Regulations

Biotech stocks surge as people are ‘hungry’ for good news on the coronavirus

April 17, 2020


Biotech stocks surged Friday after new details on a closely watched clinical trial lifted hopes that scientists may be close to a treatment for the coronavirus, which continues to maintain its foothold across the globe after emerging a little over […]

FDA, Pricing, Regulations

Televangelist Bakker, companies warned by FDA, FTC on fraudulent coronavirus claims

March 11, 2020

Via: Biopharma Dive

The FDA and the FTC said they will crack down quickly on people trying to take advantage of consumers concerned about the coronavirus infection outbreak. An “aggressive surveillance program” is monitoring social media, online marketplaces and complaints from consumers, they […]

FDA, Pricing, Regulations

Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19

March 9, 2020

Via: BioSpace

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and violate federal law. […]

Clinical Trials, Pricing, Regulations, Research and Development

AIM, Cocrystal, CEL-SCI, Beroni Pursue Coronavirus Treatment Candidates

March 9, 2020

Via: Genetic Engineering and Biotechnology News

Investors have sent shares of three biopharmas zooming since Friday afternoon based on announcements that they are developing treatments for SARS-CoV-2, the virus at the center of the global COVID-19 outbreak—while a U.S./Australian biopharma today disclosed plans to advance a […]